Bolt Biotherapeutics, Inc. BOLT
6.26 USD -0.04 (-0.63%)
At closeNov 12, 2026, 5:36 AM EST
5.95 -0.31 -4.95%
Pre-market · Nov 12, 5:36 AM ET
6.18 Day range 6.38
3.10 52-week range 7.78
- YTD
- +14.44%
- 1 year
- +30.15%
BOLT revenue history
Revenue is income from the company’s ordinary business activities.
7,695,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 7,695,000 | 5,000 | 0.07% |
| FY 2024 | 2024-12-31 | 7,690,000 | -186,000 | -2.36% |
| FY 2023 | 2023-12-31 | 7,876,000 | 2,147,000 | 37.48% |
| FY 2022 | 2022-12-31 | 5,729,000 | 4,469,000 | 354.68% |
| FY 2021 | 2021-12-31 | 1,260,000 | 1,029,000 | 445.45% |
| FY 2020 | 2020-12-31 | 231,000 | 16,000 | 7.44% |
| FY 2019 | 2019-12-31 | 215,000 | 215,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:21.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.